title: Severe opioid withdrawal due to misuse of new combined morphine and naltrexone product (Embeda).
authors.forename: David H
authors.initials: DH
authors.lastname: Jang
authors.forename: John C
authors.initials: JC
authors.lastname: Rohe
authors.forename: Robert S
authors.initials: RS
authors.lastname: Hoffman
authors.forename: Lewis S
authors.initials: LS
authors.lastname: Nelson
mesh_terms: D000328:Adult; D004338:Drug Combinations; D005260:Female; D006801:Humans; D009020:Morphine / Q000008:administration & dosage / Q000009:adverse effects*; D009271:Naltrexone / Q000008:administration & dosage / Q000009:adverse effects*; D010353:Patient Education as Topic; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
chemical_list: D004338:Drug Combinations; C550436:morphine, naltrexone combination; D009271:Naltrexone; D009020:Morphine